Adient plc
—- Market cap
- —
- Debt
- +$2.39B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ADNT stock price vs IOVA: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at IOVA's multiple
Needs IOVA P/S.
Implied fair value · at ADNT's multiple
Needs ADNT P/S.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ADNT FY 2025 (ended Sep 30, 2025) · IOVA FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Adient plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
IOVANCE BIOTHERAPEUTICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.35x
0.00x
Net debt / EBITDA
Leverage against operating earnings
—
0.83x
Cash and equivalents
Liquid reserves on the balance sheet
—
$296.98M
Total debt
Interest-bearing obligations outstanding
$2.39B
$1.00M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMERICAN AXLE & MANUFACTURING HOLDINGS INC
ADNT vs AXL
VISTEON CORP
ADNT vs VC
DANA INC
ADNT vs DAN
BORGWARNER INC
ADNT vs BWA
FOX FACTORY HOLDING CORP
ADNT vs FOXF
BioNTech SE
ADNT vs BNTX
Moderna, Inc.
ADNT vs MRNA
GILEAD SCIENCES, INC.
ADNT vs GILD
Legend Biotech Corp
ADNT vs LEGN
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.